Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Daily Archives: January 30, 2018

Monepantel reformulation successfully increases dose and improves taste

News & Announcements 2018By Richard Hopkins January 30, 2018

BRI update_clean

Recent Articles

February 28, Top 20 Shareholders
March 1, 2021
February 26, Appendix 4D & Half Year Report
February 26, 2021
February 15, Canine Monepantel Phase IIb Lymphoma Trial Update
February 14, 2021
February 10, LUMC Covid-19 Research Update
February 10, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

PharmAust @PharmAust·

PharmAust is currently recruiting dogs with B cell lymphoma for a Phase IIb clinical trial with a non-toxic anti cancer drug

Click below to watch $PAA Executive Chairman Dr Roger Aston interviewed by @alanamclean_ on @tickerNEWSau

https://tickernews.co/programs/roger-aston-anti-cancer-drug-for-dogsmp4-8598c1

Reply on Twitter 1365081126042132480 Retweet on Twitter 1365081126042132480 Like on Twitter 13650811260421324803 Twitter 1365081126042132480

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions